Stock CLNN CLENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Clene Inc.

Equities

CLNN

US1856341029

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
0.37 USD -4.05% Intraday chart for Clene Inc. -4.27% +24.75%
05-08 Earnings Flash (CLNN) CLENE Reports Q1 Revenue $73M MT
04-16 Clene Inc. and Clene Nanomedicine, Inc. Presented the Phase 2 VISIONARY-MS Long term Extension Study Results at the 2024 American Academy of Neurology Annual Meeting in Denver CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CLENE INC. Stock Clene Inc.
 47.52M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.87B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. CLNN Stock
  4. Charts Clene Inc.
  5. Sector Chart